Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-05 Sale |
2022-12-05 4:14 pm |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
6,494 | $2.6083 | $16,938 | 161,689 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-05 4:13 pm |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas Senior VP, Finance & CAO |
1,159 | $2.59 | $3,002 | 29,347 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-05 4:12 pm |
SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
2,153 | $2.59 | $5,576 | 56,344 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-10 Option Award |
2025-01-14 5:34 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas CFO |
363,800 | $0 | 468,562 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-14 5:34 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
886,650 | $0 | 1,244,782 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-14 5:34 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director |
31,000 | $0 | 41,582 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-14 5:33 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director |
31,000 | $0 | 41,400 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-14 5:33 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director |
31,000 | $0 | 41,400 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-14 5:31 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director |
31,000 | $0 | 39,500 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-14 5:30 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | Varian John Director |
31,000 | $0 | 41,400 (Direct) |
View |
| 2025-01-10 Option Award |
2025-01-14 5:30 pm |
N/A 2035-01-10 |
SELLAS Life Sciences Group Inc. | SLS | CICIC DRAGAN SVP, Chief Development Officer |
363,800 | $0 | 479,128 (Direct) |
View |
| 2024-12-04 Other |
2024-12-05 5:06 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | CICIC DRAGAN SVP, Chief Development Officer |
8,256 | $1.13 | 123,584 (Direct) |
View |
| 2024-12-04 Other |
2024-12-05 5:05 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
28,289 | $1.13 | 386,421 (Direct) |
View |
| 2024-12-04 Other |
2024-12-05 5:05 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas CFO |
7,165 | $1.13 | 111,927 (Direct) |
View |
Ownership |
2024-06-27 4:10 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | CICIC DRAGAN SVP, Chief Development Officer |
0 | $0 | 369,584 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:04 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
397,500 | $0 | 614,921 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:03 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director |
16,000 | $0 | 20,582 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:03 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
85,000 | $0 | 167,225 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:03 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director |
16,000 | $0 | 18,500 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:02 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director |
16,000 | $0 | 20,400 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:02 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer |
50,000 | $0 | 70,918 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:01 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | Varian John Director |
16,000 | $0 | 20,400 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:00 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director |
16,000 | $0 | 20,400 (Direct) |
View |
| 2024-01-22 Option Award |
2024-01-25 06:00 am |
N/A 2034-01-22 |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas CFO |
122,000 | $0 | 176,927 (Direct) |
View |
| 2023-12-06 Other |
2023-12-08 4:11 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
4,119 | $1.08 | 86,344 (Direct) |
View |
| 2023-12-06 Other |
2023-12-08 4:10 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
12,268 | $1.08 | 229,689 (Direct) |
View |
| 2023-12-06 Other |
2023-12-08 4:10 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer |
1,082 | $1.08 | 22,000 (Direct) |
View |
| 2023-12-06 Other |
2023-12-08 4:10 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas CFO |
2,929 | $1.08 | 57,856 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:18 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
100,000 | $0 | 156,344 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:17 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas CFO |
95,000 | $0 | 124,347 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:15 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
275,500 | $0 | 437,189 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:14 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer |
57,000 | $0 | 57,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:14 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | Varian John Director |
12,000 | $0 | 13,900 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:13 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director |
12,000 | $0 | 13,900 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:11 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director |
12,000 | $0 | 13,900 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:11 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director |
12,000 | $0 | 14,082 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-03 5:10 pm |
N/A 2033-02-02 |
SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2022-08-13 Option Award |
2022-08-16 4:08 pm |
N/A 2032-08-13 |
SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director |
19,000 | $0 | 19,000 (Direct) |
View |
Ownership |
2022-08-16 4:07 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | Kalin Katherine Bach Director |
0 | $0 | 0 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-15 4:05 pm |
N/A 2032-03-14 |
SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |